BACKGROUND: Inflammation has been strongly implicated in prostate carcinogenesis, but the precise molecular mechanisms linking inflammation and carcinogenic DNA damage are not known. Induction of the polyamine catabolic enzyme, spermine oxidase (SMO) has been linked to increased reactive oxygen species (ROS) and DNA damage in human gastric and lung epithelial cells and suggest direct mechanistic links between inflammation, SMO activity, ROS production, and epithelial carcinogenesis that are likely relevant in prostate cancer. METHODS: Tissue microarrays consisting of matched normal and diseased specimens from patients diagnosed with prostate cancer, prostatic intraepithelial neoplasia (PIN), or proliferative inflammatory atrophy (PIA), as well as unaffected individuals, were stained for SMO expression and analyzed using image analysis techniques and TMAJ software tools. RESULTS: Average SMO staining was significantly higher in prostate cancer and PIN tissues compared to patient-matched benign tissues. Benign tissues from prostate cancer, PIN, and PIA patients also exhibited significantly higher mean SMO expression versus tissues from prostate disease-free patients. CONCLUSIONS: Tissues from patients diagnosed with prostate cancer and PIN exhibit, on average, locally increased SMO expression in regions of prostatic disease and higher overall SMO expression in prostatic epithelial cells compared to healthy individuals. Further studies are warranted to directly examine the role of SMO-produced ROS in prostate carcinogenesis. (c) 2008 Wiley-Liss, Inc.
BACKGROUND:Inflammation has been strongly implicated in prostate carcinogenesis, but the precise molecular mechanisms linking inflammation and carcinogenic DNA damage are not known. Induction of the polyamine catabolic enzyme, spermine oxidase (SMO) has been linked to increased reactive oxygen species (ROS) and DNA damage in human gastric and lung epithelial cells and suggest direct mechanistic links between inflammation, SMO activity, ROS production, and epithelial carcinogenesis that are likely relevant in prostate cancer. METHODS: Tissue microarrays consisting of matched normal and diseased specimens from patients diagnosed with prostate cancer, prostatic intraepithelial neoplasia (PIN), or proliferative inflammatory atrophy (PIA), as well as unaffected individuals, were stained for SMO expression and analyzed using image analysis techniques and TMAJ software tools. RESULTS: Average SMO staining was significantly higher in prostate cancer and PIN tissues compared to patient-matched benign tissues. Benign tissues from prostate cancer, PIN, and PIA patients also exhibited significantly higher mean SMO expression versus tissues from prostate disease-freepatients. CONCLUSIONS: Tissues from patients diagnosed with prostate cancer and PIN exhibit, on average, locally increased SMO expression in regions of prostatic disease and higher overall SMO expression in prostatic epithelial cells compared to healthy individuals. Further studies are warranted to directly examine the role of SMO-produced ROS in prostate carcinogenesis. (c) 2008 Wiley-Liss, Inc.
Authors: Fong-Fong Chu; R Steven Esworthy; Peiguo G Chu; Jeffrey A Longmate; Mark M Huycke; Sharon Wilczynski; James H Doroshow Journal: Cancer Res Date: 2004-02-01 Impact factor: 12.701
Authors: Masashi Nakayama; Mark L Gonzalgo; Srinivasan Yegnasubramanian; Xiaohui Lin; Angelo M De Marzo; William G Nelson Journal: J Cell Biochem Date: 2004-02-15 Impact factor: 4.429
Authors: Dennis A Faith; William B Isaacs; James D Morgan; Helen L Fedor; Jessica L Hicks; Leslie A Mangold; Patrick C Walsh; Alan W Partin; Elizabeth A Platz; Jun Luo; Angelo M De Marzo Journal: Prostate Date: 2004-11-01 Impact factor: 4.104
Authors: Wendy Devereux; Yanlin Wang; Tracy Murray Stewart; Amy Hacker; Renee Smith; Benjamin Frydman; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton; Tracey D Ward; Patrick M Woster; Robert A Casero Journal: Cancer Chemother Pharmacol Date: 2003-06-25 Impact factor: 3.333
Authors: Simon M Collin; Chris Metcalfe; Helga Refsum; Sarah J Lewis; Luisa Zuccolo; George Davey Smith; Lina Chen; Ross Harris; Michael Davis; Gemma Marsden; Carole Johnston; J Athene Lane; Marta Ebbing; Kaare Harald Bønaa; Ottar Nygård; Per Magne Ueland; Maria V Grau; John A Baron; Jenny L Donovan; David E Neal; Freddie C Hamdy; A David Smith; Richard M Martin Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05-25 Impact factor: 4.254
Authors: Katherine B D'Antonio; Antoun Toubaji; Roula Albadine; Alison M Mondul; Elizabeth A Platz; George J Netto; Robert H Getzenberg Journal: J Urol Date: 2010-02-20 Impact factor: 7.450
Authors: Amita Shukla-Dave; Mireia Castillo-Martin; Ming Chen; Jose Lobo; Nataliya Gladoun; Ana Collazo-Lorduy; Faisal M Khan; Vladimir Ponomarev; Zhengzi Yi; Weijia Zhang; Pier P Pandolfi; Hedvig Hricak; Carlos Cordon-Cardo Journal: Am J Pathol Date: 2016-10-19 Impact factor: 4.307
Authors: N Miyoshi; H Ishii; K Mimori; Y Takatsuno; H Kim; H Hirose; M Sekimoto; Y Doki; M Mori Journal: Br J Cancer Date: 2009-11-17 Impact factor: 7.640